Glucagon-like peptide-1 analogues for overweight or obese adults
dc.contributor.author | Madrid, Eva | |
dc.contributor.author | Ocara Vargas, Miranda | |
dc.contributor.author | Contreras-Vera, Catalina | |
dc.contributor.author | SaldÃas, Cristina | |
dc.contributor.author | Escobar Liquitay, Camila Micaela | |
dc.contributor.author | Novik A, Victoria | |
dc.contributor.author | Munoz, Sergio R. | |
dc.contributor.author | Bracchiglione, Javier | |
dc.date.accessioned | 2024-04-12T18:14:09Z | |
dc.date.available | 2024-04-12T18:14:09Z | |
dc.date.issued | 2022-09-08 | |
dc.description | Indexación: Scopus. | |
dc.description.abstract | Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of glucagon-like peptide-1 analogues on overweight or obese adults. Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. | |
dc.description.uri | https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015092/epdf/full | |
dc.identifier.citation | Cochrane Database of Systematic Reviews, Volume 2022, Issue 9, 8 September 2022, Article number CD015092 | |
dc.identifier.doi | 10.1002/14651858.CD015092 | |
dc.identifier.issn | 1465-1858 | |
dc.identifier.uri | https://repositorio.unab.cl/handle/ria/55904 | |
dc.language.iso | en | |
dc.publisher | John Wiley and Sons Ltd | |
dc.rights.license | CC BY 4.0 DEED Atribución 4.0 Internacional | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | |
dc.subject | Glucagon like peptide 1 | |
dc.subject | Hemoglobin A1c | |
dc.subject | Abdominal discomfort | |
dc.subject | Adult | |
dc.subject | Article | |
dc.subject | Body mass | |
dc.subject | Cardiovascular risk | |
dc.subject | Cerebrovascular accident | |
dc.subject | Constipation | |
dc.subject | Diarrhea | |
dc.subject | Dyslipidemia | |
dc.subject | Dyspepsia | |
dc.subject | Energy expenditure | |
dc.subject | Follow up | |
dc.subject | Food intake | |
dc.subject | Human | |
dc.subject | Hypertension | |
dc.subject | Nausea | |
dc.subject | Non insulin dependent diabetes mellitus | |
dc.subject | Obesity | |
dc.subject | Outcome assessment | |
dc.subject | Physical activity | |
dc.subject | Prevalence | |
dc.subject | Quality of life | |
dc.subject | Randomized controlled trial (topic) | |
dc.subject | Risk assessment | |
dc.subject | Risk factor | |
dc.subject | Sensitivity analysis | |
dc.subject | Sleep disordered breathing | |
dc.subject | Vomiting | |
dc.title | Glucagon-like peptide-1 analogues for overweight or obese adults | |
dc.type | ArtÃculo |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Madrid_Glucagon-like_peptide-1_analogues_for_overweight.pdf
- Size:
- 220.07 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: